Join the Breast Cancer, Metastatic group to help and get support from people like you.
Breast Cancer, Metastatic News (Page 3)
Related terms: Metastatic Breast Cancer
Shorter Course of Radiation May Be Safe for Women Undergoing Breast Reconstruction
WEDNESDAY, Oct. 4, 2023 – Breast cancer patients who undergo a mastectomy can probably benefit from a shorter course of more intense radiation therapy, a new study indicates. Hypofractionated...
Mammograms: An Expert Overview on Why They're So Important
SUNDAY, Oct. 1, 2023 – Mammograms have long offered early detection of breast cancer, which is why getting them regularly is crucial to women’s health, one expert says. “There are several risk fac...
Many Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
MONDAY, Sept. 25, 2023 – For patients with metastatic breast cancer receiving the PI3K inhibitor alpelisib, hyperglycemia often occurs, with a median time to onset of 16 days, according to a study...
Many Women May Overestimate Risks From Genes Tied to Breast Cancer
TUESDAY, Sept. 19, 2023 – Women who carry mutations in genes known as BRCA have an elevated risk of breast cancer. But a large, new study suggests that risk may be lower than generally believed --...
Use of AI Plus One Radiologist Noninferior for Detecting Breast Cancer
MONDAY, Sept. 18, 2023 – Double reading of screening mammograms by one radiologist plus artificial intelligence (AI) is noninferior to standard-of-care double reading by two radiologists, according...
Diet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer
FRIDAY, Sept. 15, 2023 – A home-based diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer, according to a study published online Sept. 1 in the...
Interventions Can Increase Adjuvant Endocrine Treatment Adherence
THURSDAY, Sept. 14, 2023 – Lowering medication costs and some psychosocial and reminder interventions show the most promise for promoting adjuvant endocrine therapy (AET) adherence in breast cancer...
Suzanne Somers Says Her Breast Cancer Has Returned
WEDNESDAY, Aug. 2, 2023 – Actress Suzanne Somers, who first battled breast cancer in her 50s, announced on Instagram this week that the disease recently returned. Somers, now 76, has been fighting...
Biological Aging Accelerated With Breast Cancer Diagnosis, Treatment
TUESDAY, July 25, 2023 – Breast cancer diagnosis and treatment is associated with accelerated biological aging, according to a study published online July 19 in the Journal of the National Cancer...
What Is Metastatic Breast Cancer & How Is It Treated?
MONDAY, June 26, 2023 – Metastatic breast cancer can be a daunting diagnosis, but the prognosis has improved somewhat with advances in treatment. Also known as stage 4 breast cancer, metastatic...
Mortality Rates Have Decreased for Women With Early Invasive Breast Cancer
THURSDAY, June 15, 2023 – For women with early invasive breast cancer, crude annual mortality rates and risks decreased with increasing calendar periods, according to a study published online June...
Capivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 – For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant...
FDA Approves Margenza (margetuximab-cmkb) for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
ROCKVILLE, MD, Dec. 16, 2020 (GLOBE NEWSWIRE) – MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based ...
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer
South San Francisco, CA – June 29, 2020 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo,...
FDA Approves Trodelvy (sacituzumab govitecan-hziy) for Previously-Treated Metastatic Triple Negative Breast Cancer
Morris Plains, N.J., April 22, 2020 — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today anno...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
anastrozole, letrozole, Arimidex, Herceptin, Femara, trastuzumab, tamoxifen, Ibrance